Cancer Assessed 암 평가

Sentence Examples

Discover more insights into Cancer Assessed 암 평가

Keywords frequently search together with Cancer Assessed 암 평가

Narrow sentence examples with built-in keyword filters

More Cancer Assessed 암 평가 sentence examples

10.1186/s13063-018-3083-8

Primary outcomes have been defined for three different time points: short-term complications up to 8 weeks postoperatively (n = 2800), intermediate-term changes in menopausal symptoms measured by the Menopause Rating Scale at baseline and after 1 year (n = 1670), and long-term epithelial ovarian cancer assessed through national registers after 30 years (n = 5052) (or n = 7001 for high-grade serous cancer).

1차 결과는 3가지 다른 시점에 대해 정의되었습니다. 수술 후 최대 8주까지의 단기 합병증(n= 2800), 기준선 및 1년 후 폐경 등급 척도로 측정한 폐경 증상의 중기 변화(n= 1670) , 그리고 30 년 후 국가 등록을 통해 평가된 장기 상피 난소암(n= 5052)(또는 고급 장액암의 경우 n= 7001).

Full Text

More Cancer Assessed 암 평가 sentence examples

10.2217/pme-2019-0084

Aim: To evaluate active surveillance (AS) selection, safety and durability among men with low-risk prostate cancer assessed using the clinical cell cycle risk (CCR) score, a combined clinical and molecular score.

목표: 임상 세포 주기 위험(CCR) 점수, 임상 및 분자 점수를 결합하여 평가한 저위험 전립선암 남성의 능동 감시(AS) 선택, 안전성 및 내구성을 평가합니다.

Full Text

Learn more from Cancer Assessed 암 평가

Keywords related to Cancer

Cancer Prostate Cancer Pathobiology Cancer Identified Cancer Gc Cancer Harbouring Cancer Survivability Cancer Agents Cancer Oncogene Cancer Literacy Cancer Myth Cancer Models Cancer Borealis Cancer Cell Specific Cancer Specific Cancer Hospitals Cancer Improving Cancer Examination Cancer Chemoresistance Cancer Stages Cancer Molecular Cancer Early Cancer Resistant Cancer Derived Cancer Induced Cachexia Cancer Related Gene Cancer Metastasis Cancer Primary Cancer Continuum Cancer Stem Like Cancer Human Cancer Nutrition Cancer Diagnosed Cancer Successfully Cancer Testis Cancer Transcriptomes Cancer 5637 Cancer Surgeries Cancer Microarray Cancer Segmentation Cancer Development Cancer Aggressiveness Cancer Treatments Cancer Providers Cancer Pharmacogenomics Cancer Specific Survival Cancer Breast Cancer Specimens Cancer Esmo Cancer Efficacy Cancer Ags Explore More

Keywords related to Assessed

Frailty Assessed Status Assessed Morphology Assessed Response Assessed Content Assessed Zone Assessed Remodeling Assessed Production Assessed Diversity Assessed Fitness Assessed Malnutrition Assessed Impairment Assessed Structure Assessed Implantation Assessed Process Assessed Region Assessed Athletes Assessed Fibrosis Assessed Networks Assessed Cells Assessed Diabetes Assessed Lesions Assessed Rates Assessed Soils Assessed Profile Assessed Quality Assessed Sea Assessed Mismatch Assessed Landraces Assessed Motion Assessed Formation Assessed Control Assessed Strain Assessed Features Assessed Being Assessed Tissue Assessed Children Assessed Severity Assessed Hypertension Assessed Volume Assessed Infection Assessed Structures Assessed Patterns Assessed Function Assessed Strength Assessed Involvement Assessed Be Assessed Individuals Assessed Population Assessed Obesity Assessed Explore More

Cancer Assessed 암 평가

Encyclopedia 백과사전

Feb 08, 2023

Cancer Assessed(암 평가)란 무엇입니까?

Cancer Assessed 암 평가 - Primary outcomes have been defined for three different time points: short-term complications up to 8 weeks postoperatively (n = 2800), intermediate-term changes in menopausal symptoms measured by the Menopause Rating Scale at baseline and after 1 year (n = 1670), and long-term epithelial ovarian cancer assessed through national registers after 30 years (n = 5052) (or n = 7001 for high-grade serous cancer). ^[1] Aim: To evaluate active surveillance (AS) selection, safety and durability among men with low-risk prostate cancer assessed using the clinical cell cycle risk (CCR) score, a combined clinical and molecular score. ^[2]
1차 결과는 3가지 다른 시점에 대해 정의되었습니다. 수술 후 최대 8주까지의 단기 합병증(n= 2800), 기준선 및 1년 후 폐경 등급 척도로 측정한 폐경 증상의 중기 변화(n= 1670) , 그리고 30 년 후 국가 등록을 통해 평가된 장기 상피 난소암(n= 5052)(또는 고급 장액암의 경우 n= 7001). ^[1] 목표: 임상 세포 주기 위험(CCR) 점수, 임상 및 분자 점수를 결합하여 평가한 저위험 전립선암 남성의 능동 감시(AS) 선택, 안전성 및 내구성을 평가합니다. ^[2]